Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule empirique (notation de Hill) :
C7H5IO4
Numéro CAS:
Poids moléculaire :
280.02
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352005
MDL number:
Form:
solid
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderform
solid
Quality Level
contains
stabilizer
reaction suitability
reagent type: oxidant
concentration
45 wt. % (IBX)
functional group
iodo
SMILES string
OI1(=O)OC(=O)c2ccccc12
InChI
1S/C7H5IO4/c9-7-5-3-1-2-4-6(5)8(10,11)12-7/h1-4H,(H,10,11)
InChI key
CQMJEZQEVXQEJB-UHFFFAOYSA-N
Application
Reagent used to oxidize Fmoc-protected amino alcohols to the corresponding amino aldehydes in the presence of DMSO.
A stabilized formulation of IBX (SIBX) that displays none of the explosive properties of IBX, while maintaining excellent reactivity and selectivity.
Other Notes
The material is stabilized with benzoic acid and isophthalic acid
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1 - STOT RE 1 Inhalation - STOT SE 3
target_organs
Lungs, Respiratory system
supp_hazards
Classe de stockage
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Aurélie Ozanne et al.
Organic letters, 5(16), 2903-2906 (2003-08-02)
[reaction: see text] SIBX is a nonexplosive formulation of IBX that can be used as a suspension in a variety of standard organic solvents such as refluxing EtOAc and THF to oxidize safely alcohols into aldehydes and ketones. The use
Stefanie Deike et al.
Bioorganic chemistry, 101, 104012-104012 (2020-07-20)
Aggregation of amyloid peptides results in severe neurodegenerative diseases. While the fibril structures of Aβ40 and Aβ42 have been described recently, resolution of the aggregation pathway and evaluation of potent inhibitors still remains elusive, in particular in view of the
Synthetic Communications, 37, 3493-3493 (2007)


